Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / ERYP - ERYTECH: Trials In Pancreatic Cancer

ERYP - ERYTECH: Trials In Pancreatic Cancer

Erytech Pharma S.A.
  • ERYTECH is progressing a phase 3 trial in pancreatic cancer.
  • The drug, reformulated L-asparaginase, has known anti-cancer properties but its safety profile needs to be good.
  • If that happens, then this relatively unknown stock could be a profitable investment.

For further details see:

ERYTECH: Trials In Pancreatic Cancer
Stock Information
Company Name: Erytech Pharma S.A.
Stock Symbol: ERYP
Market: NASDAQ
Menu
ERYP ERYP Quote ERYP Short ERYP News ERYP Articles ERYP Message Board
Get ERYP Alerts

News, Short Squeeze, Breakout and More Instantly...